semaglutide cardiovascular outcomes news 2025 october align more closely with attained dose than achieved weight loss Oral Semaglutide Lowers Cardiovascular Events

Meet with a dietician to create a tasty and easy personalized meal plan you'll stick to

Reddys Laboratories, and Lupin are already working on GLP-1-based therapies, preparing for increased demand once patents expire in 2026 in various global markets

Many people find it effective in managing their diabetes and improving their quality of life

Arajo AA, Pereira ASBF, Medeiros CACX, Brito GAC, Leito RFC, Arajo LS, Guedes PMM, Hiyari S, Pirih FQ

Ozempic and Wegovy both contain the same active ingredient, semaglutide, but they serve different purposes: Wegovy is specifically approved for weight management in adults and children over 12 with obesity, and for those who are overweight with related health conditions such as high blood pressure, type 2 diabetes, or high cholesterol